Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the second quarter of 2021 Management...
BEIJING, April 5, 2021 /PRNewswire/ — Recon Technology, Ltd (Nasdaq: RCON) (“Recon” or the “Company”), today announced its financial results for the first six months of Fiscal...
SINGAPORE, April 6, 2021 /PRNewswire/ — Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) (“Maxeon” or “the Company”), a global leader in solar innovation and channels, today announced its financial...
Raytheon Technologies CEO Greg Hayes commented, “Neil is a proven leader who successfully guided our Finance team through the merger. He has been instrumental in overseeing...
Strategic acquisition accelerates growth of Columbia Threadneedle Investments in EMEA, significantly broadening client offering Ameriprise Financial, Inc. (NYSE: AMP) today announced that it has signed a...
2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net Revenue of $9.6M Million Up 129% vs Prior Year;...
Albion Technology & General VCT PLC LEI number: 213800TKJUY376H3KN16 As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rules 4.1 and 6.3, Albion Technology...
NANTES, France–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2020 and provided an update on...
MINNEAPOLIS, March 26, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), is re-issuing this press release solely to correct an inadvertent decimal error in...
BEIJING, March 26, 2021 /PRNewswire/ — RLX Technology Inc. (“RLX Technology” or the “Company”) (NYSE: RLX), a leading branded e-vapor company in China, today announced its unaudited...